(−)-ent-kaur-16-ene (6), 10 and isopimara-7,15-dien (7) 12 by comparing their spectroscopic data with those in the literature.
Compound 1 was obtained as a white amorphous powder. The molecular formula was determined to be C 20 H 32 O 2 from the [M + H] + peak at m/z 305.2481 (calcd. for C 20 H 33 O 2 : 305.2481) on the HR-FAB-MS spectrum. The IR spectrum at 3421 cm −1 indicated that 1 possessed a hydroxyl group. The 1 H NMR spectrum (Table 1 ) of 1 showed three tertiary methyl groups at δ H 1.00 (s, H-20), 0.86 (s, H-19), and 0.81 (s, H-18) and one oxymethine proton at δ H 2.95 (s, H-15), and a hydroxylated methylene groups at δ H 4.03 (d, J = 12.5 Hz, H-17a) and 3.81 (d, J = 12.5 Hz, H-17b). The
13
C NMR and DEPT experiments displayed 20 carbon signals, including three methyls at δ C 33.7 (C-19), 21.7 (C-18), and 17.6 (C-20); one oxygenated tertiary carbon at δ C 65.4 (C-16), one oxygenated secondary carbon at δ C 65.7 (C-15), one oxygenated methylene carbon at δ C 59.2 (C-17), three tertiary carbons at δ C 56.1 (C-5), 50.4 (C-9), and 35.9 (C-13); eight methylene carbons at δ C 42.1 (C-3), 40.6 (C-1), 35.8 (C-14), 32.2 (C-7), 26.7 (C-12), 19.2 (C-6), 18.6 (C-2), and 18.1 (C-11); and three quaternary carbons at δ C 43.3 (C-8), 39.3 (C-10), and 33.4 (C-4), suggesting that 1 was a entkaurane diterpenoid.
10 The
C NMR spectral data were similar to ent-15β,16β-epoxy-kauran-17-ol except for the chemical shifts at C-15, C-16, and C-17. 10 The α-configuration of the epoxy ring at C-15 and C-16 (δ C 65.7 and 65.4) was assigned by the chemical shift of 13 C NMR spectrum (δ C 65.7, 69.5, and 59.9 for an β-epoxy ring at C-15, C-16, and C-17; δ C 65.3, 65.9, and 58.9 for an α-epoxy ring at C-15, C-16, and C-17).
10,13 The β-proton at C-15 was reconfirmed by the spectroscopy NOESY correlataion (H-15 (Fig. 2) . The positions of the epoxy ring and hydroxyl groups were confirmed in the HMBC spectrum by correlations H-17/C-13, H-17/C-15, and H-15/ C-13 ( Fig. 2) . The other stereochemistries of ring junctions were identified by NOE correlations (Fig. 2) . Thus, the structure of 1 was determined to be ent-15α,16α-epoxykauran-17-ol and named fritillarinol A. C-14) , 31.7 (C-12), 20.9 (C-6), 18.9 (C-2) and 18.8 (C-11); and three quaternary carbons at δ C 39.5 (C-10), 41.7 (C-8) and 33.4 (C-4), suggesting that 2 was a ent-kaurane diterpenoid. 10 The NMR data of 2 were very similar with those of (16R)-17-dimethoxy-ent-kauran-19-oic acid (2a) except for the presence of a carboxylic acid moiety.
14 The stereochemistry of 2 was assumed to be same as (16R)-17-dimethoxy-ent-kauran-19-oic acid (2a) by comparing the NMR data.
14 The stereostructure at C-16 was also determined to be same (16R) as that of (16R)-17-dimethoxyent-kauran-19-oic acid (2a), based on the chemical shifts and J values.
14 Thus, the structure of compound 2 was determined to be (16R)-17-dimethoxy-ent-kaurane and named fritillarinol B.
Experimental Section
Plant Materials. The roots of F. thunbergii (Liliaceae) (2.6 kg) were purchased at Naemome Dah, Korea in January 2012. A voucher specimen of the plant (SKKU-NPL 1201) was deposited at the School of Pharmacy of Sungkyunkwan University.
Extraction and Isolation. The half dried roots of F. thunbergii (Liliaceae) (2.6 kg) were extracted with 80% MeOH three times under reflux for 4 h. The resulting MeOH extracts (200 g) were suspended in distilled water (800 mL) and then successively partitioned with n-hexane, CHCl 3 , and hydrated n-BuOH, yielding 11 g, 7 g and 19 g, respectively. The hexane soluble fraction (11 g) was separated on a silica gel open column (230-400 mesh, 550 g), eluted in a gradient solvent system from Hex: EtOAc (20:1) to Hex: EtOAc (1:1) to give six fractions (fractions A-F). Fraction C (1.8 g) was separated over a RP-C 18 silica gel column (230-400 mesh, 90 g) with a solvent system of 90% MeOH as the eluent to give seven fractions (fr. C1-C7). Fr. C5 (98 mg) was subjected to a Lobar ® -A Si (240 × 10 mm) column, using a solvent system of Hex: EtOAc (7:1) to give five fractions (fr. C51-C55). Fr. C53 (21 mg) was purified further by preparative normal-HPLC, using a solvent system of Hex: EtOAc (4:1) to obtain 1 (14 mg). Fr. A (0.7 g) was separated on a silica gel open column (230-400 mesh, 35 g), and eluted with Hex: EtOAc (4:1) to give five fractions (fr. A1-A5). Fr. A5 (54 mg) was further purified by preparative reversephase HPLC, using a solvent system of 100% MeOH to obtain 2 (4 mg) and 3 (36 mg). Fr. A1 (20 mg) was purified further by preparative reverse-phase HPLC using a solvent system of 100% MeOH to obtain 6 (13 mg) and 7 (4 mg). Fr. F (2.6 g) was separated on a RP-C18 open column (230-400 mesh, 150 g), eluted with 85% MeOH to give five fractions (fr. F1-F5). Fr. F5 was separated on a Lobar ® -A Si (240 × 10 mm) column, using a solvent system of Hex: EtOAc (4:1) to give three fractions (fr. F51-F53). Fr. F52 (21 mg) was purified further by preparative reverse-phase HPLC using a solvent system of 100% MeOH to obtain 4 (6 mg) and 5 (6mg).
15α,16α-epoxy-17-hydroxy-ent-karane ( 
